Invented by Elliot Altman, Matthew Fuller, Gheda Alsaif, Shannon Smith, Karen Maynard, Anthony FARONE, Greenway Herbal Products LLC

The market for compositions of cannabinoids and omega-fatty acids has been growing rapidly in recent years. These compositions are becoming increasingly popular due to their potential health benefits and the ease with which they can be incorporated into a daily routine. Cannabinoids are compounds found in the cannabis plant that have been shown to have a variety of therapeutic effects, including pain relief, anti-inflammatory properties, and anxiety reduction. Omega-fatty acids, on the other hand, are essential fatty acids that are necessary for optimal health and are found in foods such as fish, nuts, and seeds. When combined, cannabinoids and omega-fatty acids can create a powerful composition that can provide numerous health benefits. For example, the combination of CBD (a cannabinoid) and omega-3 fatty acids has been shown to reduce inflammation and improve heart health. There are several methods of using compositions of cannabinoids and omega-fatty acids. One popular method is through the use of supplements, which can be taken in pill form or added to food and drinks. Another method is through the use of topical creams and lotions, which can be applied directly to the skin for localized pain relief. In addition to these methods, there are also a growing number of products that combine cannabinoids and omega-fatty acids with other natural ingredients, such as herbs and vitamins, to create even more potent compositions. These products can be found in health food stores, online retailers, and even some mainstream retailers. As the market for compositions of cannabinoids and omega-fatty acids continues to grow, it is important to ensure that consumers are educated about the potential benefits and risks associated with these products. While there is still much research to be done in this area, early studies suggest that these compositions may have a wide range of therapeutic applications. Overall, the market for compositions of cannabinoids and omega-fatty acids is an exciting and rapidly evolving field. With new products and research emerging all the time, it is clear that these compositions have the potential to revolutionize the way we approach health and wellness.

The Greenway Herbal Products LLC invention works as follows

This disclosure describes compositions containing cannabinoids, omega fatty acid, and methods for using these compositions, including, but not limited to, treating or preventing inflammation, acting as an immunosuppressant and/or an anti-cancer therapy. In certain aspects, the cannabinoid may be chosen from CBC, CBCA CBD, CBDA CBDV CBDVA CBG CBGA CBLA CBN CBNA THCV THCVA and any combination of these, or iii) a mixture approximately 1:1 equimolar CBD:CBDA. The omega fatty acids can be chosen as an omega-3 fatty (such as ALA or DHA), omega-7 fatty, or omega-9 fatty.

Background for Compositions of cannabinoids and omega-fatty acids and their methods of use

Cannabinoid Compositions

Pharmaceutical Compositions

Administration

Methods of using a cannabinoid or a composition of cannabinoid with omega fatty acids as an anti-inflammatory agent or immunosuppressant

Methods for Using Compositions as Cancer Therapeutics

Kits

Exemplary Embodiments

Examples

Materials & Methods

Cannabinoids

Example 1: DPPH Antioxidant Assay

Example 2 : Human Cellular Cytokine LPS Assay THP-1

Example 3 : Mouse LPS Cytokine animal model

Example 4 : Human Cellular U-937 Induction of Autophagy Assay

DISCUSSION

Example 5

Example 6″: Perform the Mouse LPS Cytokine Animal Model in order to evaluate the combination of 1:1 CBD:CBDA and Omega Fatty Acids

Examples 6A: Determining Dosing Effectiveness of a Cannabinoid Using the Mouse LPS Cytokine Animal Model”.

Examples 6A and 6B: Dosing Effectiveness of Omega Fatty Acids to Mice using the Mouse LPS Animal Model

Examples 6C: Determining Dosing Effectiveness of Cannabinoid and Omega Fatty Acid Compositions on Mice using the Mouse LPS Cytokine Animal Model”.

Examples 6D: Examining Efficacy and ALA, DHA and EPA Omega-3 Fatty Acids As Anti-Inflammatory Drugs

Click here to view the patent on Google Patents.